Summary Hepatitis D virus (HDV) is a small RNA virus that requires Hepatitis B Surface Antigen (HBsAg) for its envelope. Eight genotypes with more than 80 % sequence homology and many subgenotypes have been described. Worldwide prevalence of chronic hepatitis delta (CHD) is estimated at about 5 % of chronic hepatitis B cases, translating to […]
Chronic infection with HDV is considered the most aggressive and severe form of viral hepatitis, associated with an increased risk of cirrhosis and liver cancer. Due to high morbidity and mortality, there is a clear need for additional therapies for this disease. The Food and Drug Administration (FDA)’s Office of Orphan Products Development should continue […]
Summary Background & Aims The year 2023 marked the 10-year anniversary of the launch of direct-acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV). Monitoring HCV treatment trends by country, region, and globally is important to assess progress toward the World Health Organization’s 2030 elimination targets. Additionally, historical patterns can help predict the […]
Summary There is a great deal of uncertainty surrounding the prevalence of hepatitis delta virus among people living with hepatitis B virus at the population level. In this study, we aimed to better understand the burden in 25 countries and territories, to refine techniques that can be used in future analyses. We found a lower […]
English 
Spanish 
French 
Chinese 
Russian 
Arabic